BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6103879)

  • 1. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
    Mayer O; Cepelák V; Vitous J; Potmĕsil J
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of metipranolol and other blockaders of beta-receptors in experimental animals and man].
    Mayer O; Trcka V
    Cas Lek Cesk; 1982 Sep; 121(34-35):1083-6. PubMed ID: 6127161
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
    Vanĕcek M; Trcka V; Helfert I
    Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
    Ceremuzynski L; Zaleska T; Nauman J; Nauman A; Zalewski A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):244-9. PubMed ID: 38215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cardiac output, induced by metipranolol and other beta-blockers, in dogs.
    Helfert I; Vanĕcek M; Trcka V
    Acta Univ Carol Med (Praha); 1980; 26(7-8):345-9. PubMed ID: 6126107
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
    de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
    Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
    Hugues FC; Le Jeunne C; Munera Y; Dufier JL
    J Fr Ophtalmol; 1987; 10(8-9):485-90. PubMed ID: 2892874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of action of the new beta-adrenolytic drug VUL 111 upon the cardiovascular system. 1. Beta-adrenolytic activity on peroral administration and ways of metabolic degradation (author's transl)].
    Drimal J; Strízová K; Borovicová F; Gibala P; Stefek M; Kovácik V
    Bratisl Lek Listy; 1978 Jul; 70(1):11-28. PubMed ID: 28818
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of cardiovascular responses to emotional stress in preventive cardiology (author's transl)].
    Slabý A; Frantík E; Horváth M; Josífko M
    Cas Lek Cesk; 1981 Nov; 120(46):1393-8. PubMed ID: 6119155
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol.
    Planz G; Haass H; Lamberts B
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):469-73. PubMed ID: 6128312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma bevantolol concentration and heart rate in rabbits.
    Liu XQ; Ye XL; Zhu HQ; Huang SK
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):200-2. PubMed ID: 7901961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stereospecificity of beta-blocker effects on the glaucomatous eye].
    Krieglstein GK; Schrems W
    Fortschr Ophthalmol; 1984; 81(2):127-9. PubMed ID: 6145665
    [No Abstract]   [Full Text] [Related]  

  • 16. Pamatolol: phase I evaluation of the pharmacodynamics of a cardioselective beta adrenoceptor blocking drug.
    Carruthers SG; Hosler JP; Pentikainen P; Azarnoff DL
    Clin Pharmacol Ther; 1978 Aug; 24(2):168-74. PubMed ID: 28193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of the beta-receptor blocker metipranolol in patients with liver cirrhosis (author's transl)].
    Seyfried C; Ledermann H; Rennekamp H; L'age M; Abshagen U
    Dtsch Med Wochenschr; 1982 Jan; 107(1):21-6. PubMed ID: 6120063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacology of Metipranolol (trimepranol injection VUFB, Spofa tablets). The importance of clinical dosages].
    Mayer O; Cepelák V; Vitous J
    Vnitr Lek; 1981 Feb; 27(2):160-71. PubMed ID: 6110280
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle.
    Knezl V; Magna D; Sotníková R; Drímal J
    Arzneimittelforschung; 1994 Jan; 44(1):7-12. PubMed ID: 7907875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose-response relationship of beta-adrenergic blocking agents].
    Seyberth H
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1663-5. PubMed ID: 4150008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.